Table 4.
Meta-regression findings.
| Variable | Age | Percentage of women | Follow-up period | |||||||||
| Value, n | β (95% CI) | P value | Value, n | β (95% CI) | P value | Value, n | β (95% CI) | P value | ||||
| Body composition |
|
|
|
|
|
|
|
|
|
|||
|
|
BMI (kg/m2) | 6 | 0.04 (−0.37 to 0.45) | .81 | 6 | 0.07 (0.03 to 0.12) | .01 | 6 | −0.01 (−0.03 to 0.01) | .21 | ||
|
|
Waist circumference (cm) | 8 | 0.06 (−0.68 to 0.80) | .86 | 8 | 0.01 (−0.16 to 0.18) | .85 | 8 | −0.02 (−0.03 to 0.01) | .005 | ||
| Blood pressure |
|
|
|
|
|
|
|
|
|
|||
|
|
SBPa (mmHg) | 8 | −0.28 (−1.76 to 1.19) | .65 | 8 | −0.12 (−0.44 to 0.21) | .41 | 8 | 0.00 (−0.04 to 0.04) | .92 | ||
|
|
DBPb (mmHg) |
|
0.49 (−0.02 to 1.01) | .057 | 8 | 0.08 (−0.06 to 0.22) | .23 | 8 | 0.00 (−0.02 to 0.02) | .87 | ||
| Glucose tolerance |
|
|
|
|
|
|
|
|
|
|||
|
|
HbA1cc (mg/dL) | 5 | −0.29 (−1.10 to 0.52) | .34 | 5 | 0.04 (−0.08 to 0.16) | .37 | 5 | 0.01 (−0.04 to 0.07) | .449 | ||
|
|
FPGd (mg/dL) | 7 | 0.33 (−0.12 to 0.78) | .12 | 7 | 0.08 (−0.04 to 0.19) | .42 | 7 | 0.04 (−0.02 to 0.03) | .75 | ||
| Lipid profile |
|
|
|
|
|
|
|
|
|
|||
|
|
Total cholesterol (mg/dL) | 5 | 1.58 (−1.10 to 4.26) | .16 | 5 | 0.28 (−0.44 to 1.00) | .31 | 5 | 0.00 (−0.02 to 0.02) | .52 | ||
|
|
HDL-Ce (mg/dL) | 8 | 0.24 (−0.08 to 0.56) | .12 | 8 | 0.01 (−0.11 to 0.13) | .80 | 8 | 0.00 (0.00 to 0.00) | .11 | ||
|
|
LDL-Cf (mg/dL) | 5 | 0.73 (−1.21 to 2.67) | .32 | 5 | 0.10 (−0.34 to 0.53) | .52 | 5 | 0.00 (−0.01 to 0.01) | .75 | ||
|
|
Triglyceride (mg/dL) | 8 | 0.74 (−2.97 to 4.45) | .64 | 8 | 0.49 (0.05 to 0.94) | .03 | 8 | 0.00 (−0.01 to 0.01) | .99 | ||
aSBP: systolic blood pressure.
bDBP: diastolic blood pressure.
cHbA1c: glycated hemoglobin A1c.
dFPG: fasting plasma glucose.
eHDL-C: high-density lipoprotein cholesterol.
fLDL-C: low density lipoprotein- cholesterol.